+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05786131

Study Comparing Complete Versus Culprit-Only PCI in Patients with NSTEMI and Multivessel Coronary Artery Disease

Led by Leipzig Heart Science gGmbH · Updated on 2025-01-16

3390

Participants Needed

58

Research Sites

25 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether performing percutaneous coronary intervention PCI on all significant blockages in patients with non-ST-segment elevation myocardial infarction NSTEMI and multivessel coronary artery disease is better than treating only the main culprit lesion. This open-label, randomized, controlled, multicenter trial aims to compare these two approaches to understand which provides better outcomes for patients with this heart condition. Participants will be randomly assigned to one of two groups. One group will receive optimal medical therapy and PCI only on the culprit lesion, with no further intervention on other blockages unless certain emergency criteria occur. The other group will receive complete revascularization of all significant non-culprit lesions, either during the initial procedure, hospitalization, or within 45 days after the initial PCI. During the study, participants will be followed for an average of two years to monitor outcomes including cardiovascular death, rehospitalization for heart attacks, and other heart-related events. Researchers will also assess quality of life and complications such as bleeding, stroke, and kidney injury at various time points. The study involves regular evaluations and aims to gather comprehensive data to determine the best treatment strategy for these patients.

CONDITIONS

Brief Title

Complete Revascularization Versus Culprit Lesion Only PCI in NSTEMI

Research Team

H

Holger Thiele, MD, Prof. Dr.

H

Hans-Josef Feistritzer, MD, PhD; Assoc. Prof.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here